Accellacare - Piedmont — Statesville, North Carolina

Accellacare - Piedmont is a clinical research site located in Statesville, North Carolina, United States 28625.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Accellacare - Piedmont has participated in 7 clinical trials with 3 currently active.

Therapeutic areas: COVID-19, SARS-COV-2 Infection, Respiratory Syncytial Virus Infections.

Sponsors: BioNTech SE, Bavarian Nordic, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accellacare - Piedmont?

Accellacare - Piedmont has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accellacare - Piedmont conducted?

Accellacare - Piedmont has 7 clinical trials on record, with 3 currently active. Their work covers COVID-19, SARS-COV-2 Infection, Respiratory Syncytial Virus Infections.

Is Accellacare - Piedmont accredited by Crixeo Health?

Yes — Accellacare - Piedmont holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Accellacare - Piedmont?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.